The outbreak of the COVID-19 in 2020 has dramatically changed people's living needs. The demand for antibacterial products has soared, such as antibacterial agents, hand sanitizers, wipes, and masks.
As we all know, some pathogenic microorganisms are resident in the human body, and they coexist and interact with humans, which is what we often say is immunity.
But if the body's immune system becomes weak, bacteria and viruses will damage the human mucosa, muscles, lungs, stomach, and other organs. Severely it will cause systemic inflammation syndrome and multiple organ damage.
Recently, basketball players have frequently been infected with the new crown virus. It is because basketball players often push their bodies to the limit. Then lead to hypoactive immune function, which is artificial "immunosuppression". And basketball players are often in confined spaces such as dressing rooms, meeting rooms, hotel rooms, etc., which is prone to large-scale infections.
Pathogenic microorganisms can be spread through droplets, contact with objects, aerosols, feces, food, water, etc. They cause major epidemics such as influenza, plague, tetanus, typhoid, pneumonia, syphilis, cholera, and tuberculosis that we know and disease.
Therefore, although some bacteria and viruses coexist with the human body, people still worry about them, fearing that they threaten their health.
The birth of nano-silver antibacterial daily necessities is to prevent the infection of pathogenic microorganisms caused by droplets and contact.
The impact of the epidemic on humans
In the Middle Ages of Europe, the outbreak of the "Black Death" claimed the lives of tens of millions of people, and people saw the danger of pathogenic bacteria.
From 1918 to 1920, a pandemic that swept across Europe, America and Asia killed 50 million to 100 million people.
In 1910, a plague was introduced into Harbin by the Middle East Railway. The epidemic lasted for more than 6 months and swept through half of China, killing more than 60,000 people.
In 1995, bacterial infections (cholera, dysentery, pneumonia, etc.) caused 17 million deaths worldwide, accounting for 32.7% of the total deaths.
In 1998, "Beijing Youth Daily" reported that 50 million people were hospitalized each year, and about 10% had nosocomial infections during treatment.
In 2003, the SARS incident affected thousands of people.
In 2009, influenza A H1N1 caused approximately 3,900 American deaths; 714 deaths in China.
In 2014, the Ebola virus was deadly in Guinea, Liberia and Sierra Leone in West Africa, where more than 20,000 people were infected.
In 2019, the new coronavirus began to spread in December; now, the epidemic has spread to 159 countries and regions.
The interval between large-scale outbreaks is getting shorter and shorter. Each occurrence is unknown and rapid. In the face of the epidemic, we not only need to respond quickly and deploy countermeasures. We also need to understand not only where the pathogenic microorganisms come from, but also how they will be transmitted. How to prevent the emergence of reinfection. To prevent the outbreak of the epidemic; silver antimicrobial agents appeared in the ancient Egyptian era, which is the product of people to curb the infection of bacteria and viruses.
The use of colloidal silver antibacterial solution will not affect the "beneficial" microorganisms in the human body. The colloidal silver antibacterial solution acts on the surface of objects in contact with the human body adsorb those harmful pathogenic microorganisms and avoid their accumulation, reproduction, and infection.